Skip directly to content

medication-independent

A-05: Short pulse laser system for the treatment of age-related macular degeneration

Developing a laser procedure (frequency-doubled Nd:YAG solid-state lasers) for treating pathological changes in the retinal pigment epithelium in connection with age-related macula degeneration. For the first time ever, the product to be developed will provide a treatment option for the early form of age-related macula degeneration, which progressively leads to a loss of central vision and, with it, the ability to read. In Germany alone, a one-off market for up to 3,000,000 people can be expected for this indication.

The goal is to develop a system that has decisive advantages over existing